
Chiral Organic Compounds
Chiral organic compounds are molecules that possess non-superimposable mirror images, a property known as chirality, which plays a crucial role in various chemical and biological processes. These compounds are essential in the development of pharmaceuticals, agrochemicals, and fine chemicals, where the specific orientation of molecules can significantly impact their function and efficacy. At CymitQuimica, we offer a comprehensive range of high-purity chiral organic compounds, including enantiomers and diastereomers, meticulously sourced and tested to meet the stringent demands of both research and industrial applications. Our catalog includes chiral catalysts, auxiliaries, and building blocks that are pivotal in asymmetric synthesis and stereoselective reactions. By providing top-quality chiral organic compounds, we support researchers and professionals in achieving precise and efficient stereochemical outcomes, driving advancements and innovation in fields such as medicinal chemistry, biotechnology, and materials science.
Products of "Chiral Organic Compounds"
Sort by
5-[(3S)-Dithiolan-3-yl]pentanoic acid
CAS:Formula:C8H14O2S2Purity:97%Color and Shape:SolidMolecular weight:206.32556000000002D-Phenylalanine ethyl ester hydrochloride
CAS:Formula:C11H16ClNO2Purity:97%Color and Shape:SolidMolecular weight:229.7032Carbamic acid, N-[(1R,2S)-2-(aminomethyl)cyclohexyl]-, 1,1-dimethylethyl ester, rel-
CAS:Formula:C12H24N2O2Purity:98%Color and Shape:SolidMolecular weight:228.3312(3aS,6aS)-1-Methyl-hexahydropyrrolo[3,4-b]pyrrole Dihydrochloride
CAS:Formula:C7H15ClN2Purity:97%Molecular weight:162.6604Isopimaric Acid
CAS:Controlled ProductApplications A potent novel activators of large-conductance Ca2+-activated K+ channel. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Imaizumei, Y. et al.: Mol. Pharmacol., 62, 836 (2002); Chang, S. et al.: AM. J. Physiol., 298, F1416 (2010);Formula:C20H30O2Purity:>90%Color and Shape:Off-WhiteMolecular weight:302.45(1S,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one
CAS:Formula:C10H16OPurity:98%Color and Shape:SolidMolecular weight:152.2334A 54556A (~90%)
CAS:Controlled ProductFormula:C38H50N6O8Purity:~90%Color and Shape:NeatMolecular weight:718.84Salinomycin sodium salt
CAS:Formula:C42H69NaO11Purity:98%Color and Shape:SolidMolecular weight:772.9804(2S,4R)-tert-Butyl 4-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)pyrrolidine-1-carboxylate
CAS:Formula:C16H33NO4SiPurity:95%Color and Shape:SolidMolecular weight:331.523(S)-(-)-XylBINAP
CAS:Formula:C52H48P2Purity:>97.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:734.90(3R,5S)-Atorvastatin Sodium Salt
CAS:Controlled ProductStability Hygroscopic Applications Atorvastatin impurity in bulk drug and tablets. References Posvar, E., et al.: J. Clin. Pharmacol., 36, 728 (1996), Lea, A., et al.: Drugs, 53, 828 (1997), Miao, X., et al.: J. Chromatogr., 998, 133 (2003),Formula:C33H34FN2O5·NaColor and Shape:NeatMolecular weight:580.623-Piperidinecarboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester, (3R,4R)-rel-
CAS:Formula:C12H22N2O4Purity:97%Color and Shape:SolidMolecular weight:258.31413-Furanmethanol, tetrahydro-, (3S)-
CAS:Formula:C5H10O2Purity:97%Color and Shape:LiquidMolecular weight:102.1317(4S)-4-(propan-2-yl)-1,3-oxazolidin-2-one
CAS:Formula:C6H11NO2Purity:97%Color and Shape:SolidMolecular weight:129.157Dimethyl L-(+)-Tartrate
CAS:Formula:C6H10O6Purity:>98.0%(GC)Color and Shape:White to Almost white powder to crystalMolecular weight:178.14(R)-2-(4-Hydroxyphenoxy)propanoic acid
CAS:Formula:C9H10O4Purity:98%Color and Shape:SolidMolecular weight:182.1733Glycine, N,N'-(1R,2R)-1,2-cyclohexanediylbis[N-(carboxymethyl)-, hydrate (1:1), rel-
CAS:Formula:C14H24N2O9Purity:98%Color and Shape:SolidMolecular weight:364.34835999999984Alpha-Zearalenol-d7
CAS:Controlled ProductFormula:C18H17D7O5Color and Shape:Off White SolidMolecular weight:327.42